Brief: Hengrui Pharmaceuticals Signs SHR-4849 Project License Agreement With Ideaya Biosciences
29/12/2024 08:49
Dec 29 (Reuters) - Jiangsu Hengrui Pharmaceuticals Co
Ltd 600276.SS :
* SAYS CO SIGNS EARNINGS PER SHARE-4849 PROJECT LICENSE
AGREEMENT
WITH IDEAYA BIOSCIENCES
Source text
Further company coverage: 600276.SS
(Reporting by Hong Kong Newsroom)
((donny.kwok@thomsonreuters.com; +852 3462 7745;))
Recent news on IDEAYA Biosciences
See all newsBrief: Ideaya Biosciences And Servier Announce Data From Three Clinical Trials At Esmo 2026 Supporting The Potential Of Darovasertib To Become A Foundational New Therapy For Patients Across The Treatment Journey Of Uveal Melanoma
Brief: Ideaya Biosciences Announces The Promotion Of Dr. Michael White To President, Research And Development
Brief: Ideaya Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Ideaya Biosciences Inc Reports Results For The Quarter Ended June 30: Earnings Summary
U.S. STOCKS ON THE MOVE-Cleveland-Cliffs, Ciena Corp, Nokia Oyj